Filing Flows

Filing Flows › Comparisons › DVA vs AGL

Davita vs agilon health: DVA and AGL compared

Davita is the larger company: $3.6B of revenue in its latest quarter (Q3 2026) against $1.5B for agilon health (Q3 2026). agilon health is growing faster (+6% against +5% a year earlier). Davita is more profitable, with an operating margin of 14.0% against 1.6%.

Davita vs agilon health, latest quarterDavita vs agilon health, latest quarterDavita (DVA)agilon health (AGL)Revenue$3.6B$1.5BRevenue growth, Y/Y+5%+6%Operating margin14.0%1.6%Net margin6.2%2.3%Free cash flow$276M$46.6M

Where the money goes: DVA and AGL

Davita (DVA) · Q3 2026

Davita, Q3 2026: revenue $3.6B (+5% year over year), operating margin 14.0%, net earnings $223M, operating cash flow $519M. The chart follows the revenue to costs, profit and cash.

agilon health (AGL) · Q3 2026

agilon health, Q3 2026: revenue $1.5B (+6% year over year), operating margin 1.6%, net earnings $34.9M, operating cash flow $49.9M. The chart follows the revenue to costs, profit and cash.

Davita revenue by segment, Q3 2026Davita revenue by segment, Q3 2026U. S. Dialysis and Related Lab Se…$3.0BOther - Ancillary Services$550M
Davita (DVA)agilon health (AGL)
Latest quarterQ3 2026Q3 2026
Revenue$3.6B$1.5B
Revenue growth, Y/Y+5%+6%
Operating margin14.0%1.6%
Net earnings$223M$34.9M
Net margin6.2%2.3%
Operating cash flow$519M$49.9M
Free cash flow$276M$46.6M
Market value$12.5B$1.9B
P/E14.2×—
Analysts’ mean target$222.29$117.75

Where the revenue comes from

Davita

Questions

Which is bigger, Davita or agilon health?

Davita is the larger company: $3.6B of revenue in its latest quarter (Q3 2026) against $1.5B for agilon health (Q3 2026).

Is Davita or agilon health growing faster?

agilon health is growing faster (+6% against +5% a year earlier).

Which is more profitable, Davita or agilon health?

Davita is more profitable, with an operating margin of 14.0% against 1.6%.

More: Davita earnings · how Davita makes money · agilon health earnings · how agilon health makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Nov 4, 2026). Fiscal quarters can end on different dates. Not investment advice.